A detailed history of Weybosset Research & Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Weybosset Research & Management LLC holds 2,080 shares of ABT stock, worth $234,291. This represents 0.08% of its overall portfolio holdings.

Number of Shares
2,080
Previous 2,080 -0.0%
Holding current value
$234,291
Previous $216,000 9.72%
% of portfolio
0.08%
Previous 0.08%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 18, 2024

BUY
$90.19 - $110.4 $187,595 - $229,632
2,080 New
2,080 $228,000
Q2 2023

Jul 12, 2023

SELL
$100.78 - $112.29 $87,678 - $97,692
-870 Reduced 31.64%
1,880 $205,000
Q1 2023

Apr 14, 2023

BUY
$96.86 - $114.01 $4,843 - $5,700
50 Added 1.85%
2,750 $278,000
Q3 2022

Nov 07, 2022

BUY
$96.76 - $112.03 $29,028 - $33,609
300 Added 12.5%
2,700 $261,000
Q2 2022

Aug 08, 2022

BUY
$102.07 - $123.37 $244,967 - $296,088
2,400 New
2,400 $261,000
Q4 2021

Jan 19, 2022

SELL
$115.53 - $141.46 $283,048 - $346,577
-2,450 Closed
0 $0
Q3 2021

Oct 25, 2021

SELL
$116.66 - $129.06 $104,994 - $116,154
-900 Reduced 26.87%
2,450 $289,000
Q2 2021

Jul 26, 2021

BUY
$105.79 - $124.53 $31,737 - $37,359
300 Added 9.84%
3,350 $388,000
Q4 2020

Jan 21, 2021

SELL
$105.0 - $114.42 $31,500 - $34,326
-300 Reduced 8.96%
3,050 $334,000
Q3 2020

Oct 28, 2020

SELL
$91.64 - $111.29 $128,296 - $155,806
-1,400 Reduced 29.47%
3,350 $365,000
Q2 2019

Jul 22, 2019

BUY
$72.88 - $85.0 $10,932 - $12,750
150 Added 3.26%
4,750 $399,000
Q4 2018

Jan 25, 2019

BUY
$65.56 - $74.27 $6,556 - $7,427
100 Added 2.22%
4,600 $333,000
Q1 2018

May 02, 2018

SELL
$56.27 - $63.62 $5,627 - $6,362
-100 Reduced 2.17%
4,500 $270,000
Q3 2017

Oct 23, 2017

BUY
$48.06 - $53.64 $221,076 - $246,744
4,600
4,600 $245,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Weybosset Research & Management LLC Portfolio

Follow Weybosset Research & Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weybosset Research & Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weybosset Research & Management LLC with notifications on news.